<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000008c8317e> <http://rdf.freebase.com/ns/base.bioventurist.sales.company_reporting> <http://rdf.freebase.com/ns/en.genentech>.
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000008c8317e> <http://rdf.freebase.com/ns/base.bioventurist.sales.area> <http://rdf.freebase.com/ns/en.world_wide>.
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000008c8317e> <http://rdf.freebase.com/ns/base.bioventurist.sales.amount> "2071000000"^^<http://www.w3.org/2001/XMLSchema#long>.
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000008c8317e> <http://rdf.freebase.com/ns/base.bioventurist.sales.year> "2006".
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000008c8317e> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://rdf.freebase.com/ns/base.bioventurist.sales>.
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000009e7d94a> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://rdf.freebase.com/ns/common.topic>.
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000009e7d94a> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://rdf.freebase.com/ns/base.bioventurist.indication>.
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000009e7d94a> <http://rdf.freebase.com/ns/base.bioventurist.indication.therapeutic> <http://rdf.freebase.com/ns/en.rituximab>.
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000009e7d94a> <http://rdf.freebase.com/ns/base.bioventurist.indication.disease> <http://rdf.freebase.com/ns/en.lupus_nephritis>.
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000009e7d94a> <http://rdf.freebase.com/ns/base.bioventurist.indication.phase_of_development> <http://rdf.freebase.com/ns/en.phase_iii_clinical_trial>.
_:zUaFDsvC1541 <http://rdf.freebase.com/ns/type.key.namespace> <http://rdf.freebase.com/ns/wikipedia.en>.
_:zUaFDsvC1541 <http://rdf.freebase.com/ns/type.value.value> "Rituxan".
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000008e2e040> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://rdf.freebase.com/ns/common.topic>.
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000008e2e040> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://rdf.freebase.com/ns/base.bioventurist.indication>.
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000008e2e040> <http://rdf.freebase.com/ns/base.bioventurist.indication.disease> <http://rdf.freebase.com/ns/en.b-cell_lymphoma>.
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000008e2e040> <http://rdf.freebase.com/ns/base.bioventurist.indication.phase_of_development> <http://rdf.freebase.com/ns/en.on_the_market>.
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000008e2e040> <http://rdf.freebase.com/ns/base.bioventurist.indication.therapeutic> <http://rdf.freebase.com/ns/en.rituximab>.
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000009e7d93a> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://rdf.freebase.com/ns/common.topic>.
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000009e7d93a> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://rdf.freebase.com/ns/base.bioventurist.indication>.
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000009e7d93a> <http://rdf.freebase.com/ns/base.bioventurist.indication.therapeutic> <http://rdf.freebase.com/ns/en.rituximab>.
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000009e7d93a> <http://rdf.freebase.com/ns/base.bioventurist.indication.disease> <http://rdf.freebase.com/ns/en.anca_associated_vasculitides>.
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000009e7d93a> <http://rdf.freebase.com/ns/base.bioventurist.indication.phase_of_development> <http://rdf.freebase.com/ns/en.phase_iii_clinical_trial>.
<http://rdf.freebase.com/ns/en.rituximab> <http://rdf.freebase.com/ns/base.bioventurist.product.technology_involved> <http://rdf.freebase.com/ns/en.chimeric_monoclonal_antibody>.
<http://rdf.freebase.com/ns/en.rituximab> <http://rdf.freebase.com/ns/base.bioventurist.product.technology_involved> <http://rdf.freebase.com/ns/en.monoclonal_antibodies>.
<http://rdf.freebase.com/ns/en.rituximab> <http://rdf.freebase.com/ns/base.bioventurist.product.stage_of_development> <http://rdf.freebase.com/ns/en.on_the_market>.
<http://rdf.freebase.com/ns/en.rituximab> <http://rdf.freebase.com/ns/type.object.key> _:zUaFDsvC1541.
<http://rdf.freebase.com/ns/en.rituximab> <http://rdf.freebase.com/ns/type.object.key> _:zUaFDsvC1544.
<http://rdf.freebase.com/ns/en.rituximab> <http://rdf.freebase.com/ns/type.object.key> _:zUaFDsvC1543.
<http://rdf.freebase.com/ns/en.rituximab> <http://rdf.freebase.com/ns/type.object.key> _:zUaFDsvC1542.
<http://rdf.freebase.com/ns/en.rituximab> <http://rdf.freebase.com/ns/type.object.key> _:zUaFDsvC1539.
<http://rdf.freebase.com/ns/en.rituximab> <http://rdf.freebase.com/ns/type.object.key> _:zUaFDsvC1540.
<http://rdf.freebase.com/ns/en.rituximab> <http://rdf.freebase.com/ns/base.bioventurist.product.brand_name> "Rituxan"@en.
<http://rdf.freebase.com/ns/en.rituximab> <http://rdf.freebase.com/ns/base.bioventurist.product.brand_name> "MabThera"@en.
<http://rdf.freebase.com/ns/en.rituximab> <http://rdf.freebase.com/ns/base.bioventurist.bv_therapeutic.biomolecule_or_target> <http://rdf.freebase.com/ns/en.cd20>.
<http://rdf.freebase.com/ns/en.rituximab> <http://rdf.freebase.com/ns/medicine.medical_treatment.used_to_treat> <http://rdf.freebase.com/ns/en.dermatomyositis>.
<http://rdf.freebase.com/ns/en.rituximab> <http://rdf.freebase.com/ns/medicine.medical_treatment.used_to_treat> <http://rdf.freebase.com/ns/en.rheumatoid_arthritis>.
<http://rdf.freebase.com/ns/en.rituximab> <http://rdf.freebase.com/ns/base.bioventurist.bv_therapeutic.composition> <http://rdf.freebase.com/ns/en.monoclonal_antibodies>.
<http://rdf.freebase.com/ns/en.rituximab> <http://creativecommons.org/ns#attributionName> "Source: Freebase - The World's database".
<http://rdf.freebase.com/ns/en.rituximab> <http://www.w3.org/1999/xhtml/vocab#license> <http://creativecommons.org/licenses/by/3.0/>.
<http://rdf.freebase.com/ns/en.rituximab> <http://rdf.freebase.com/ns/type.object.name> "Rituximab"@de.
<http://rdf.freebase.com/ns/en.rituximab> <http://rdf.freebase.com/ns/type.object.name> "Rytuksymab"@pl.
<http://rdf.freebase.com/ns/en.rituximab> <http://rdf.freebase.com/ns/type.object.name> "Rituximab"@fr.
<http://rdf.freebase.com/ns/en.rituximab> <http://rdf.freebase.com/ns/type.object.name> "\u30EA\u30C4\u30AD\u30B7\u30DE\u30D6"@ja.
<http://rdf.freebase.com/ns/en.rituximab> <http://rdf.freebase.com/ns/type.object.name> "Rituximab"@en.
<http://rdf.freebase.com/ns/en.rituximab> <http://rdf.freebase.com/ns/base.bioventurist.product.developed_by> <http://rdf.freebase.com/ns/en.biogen_idec>.
<http://rdf.freebase.com/ns/en.rituximab> <http://rdf.freebase.com/ns/base.bioventurist.product.developed_by> <http://rdf.freebase.com/ns/en.genentech>.
<http://rdf.freebase.com/ns/en.rituximab> <http://rdf.freebase.com/ns/common.topic.article> <http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000000489acf>.
<http://rdf.freebase.com/ns/en.rituximab> <http://rdf.freebase.com/ns/medicine.drug.atc_code> "L01XC02".
<http://rdf.freebase.com/ns/en.rituximab> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://rdf.freebase.com/ns/common.topic>.
<http://rdf.freebase.com/ns/en.rituximab> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://rdf.freebase.com/ns/base.bioventurist.bv_therapeutic>.
<http://rdf.freebase.com/ns/en.rituximab> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://rdf.freebase.com/ns/base.bioventurist.topic>.
<http://rdf.freebase.com/ns/en.rituximab> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://rdf.freebase.com/ns/medicine.medical_treatment>.
<http://rdf.freebase.com/ns/en.rituximab> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://rdf.freebase.com/ns/base.bioventurist.product>.
<http://rdf.freebase.com/ns/en.rituximab> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://rdf.freebase.com/ns/medicine.drug>.
<http://rdf.freebase.com/ns/en.rituximab> <http://rdf.freebase.com/ns/base.bioventurist.product.sales> <http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000008c8317e>.
<http://rdf.freebase.com/ns/en.rituximab> <http://rdf.freebase.com/ns/base.bioventurist.product.sales> <http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000008c83170>.
<http://rdf.freebase.com/ns/en.rituximab> <http://rdf.freebase.com/ns/base.bioventurist.product.sales> <http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000008c83177>.
<http://rdf.freebase.com/ns/en.rituximab> <http://creativecommons.org/ns#attributionURL> <http://www.freebase.com/view/en/rituximab>.
<http://rdf.freebase.com/ns/en.rituximab> <http://www.w3.org/2002/07/owl#sameAs> <http://dbpedia.org/resource/MabThera>.
<http://rdf.freebase.com/ns/en.rituximab> <http://www.w3.org/2002/07/owl#sameAs> <http://dbpedia.org/resource/Rituximab>.
<http://rdf.freebase.com/ns/en.rituximab> <http://www.w3.org/2002/07/owl#sameAs> <http://dbpedia.org/resource/Mabthera>.
<http://rdf.freebase.com/ns/en.rituximab> <http://www.w3.org/2002/07/owl#sameAs> <http://dbpedia.org/resource/Rituxan>.
<http://rdf.freebase.com/ns/en.rituximab> <http://rdf.freebase.com/ns/base.bioventurist.bv_therapeutic.indication_or_disease> <http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000008e2e040>.
<http://rdf.freebase.com/ns/en.rituximab> <http://rdf.freebase.com/ns/base.bioventurist.bv_therapeutic.indication_or_disease> <http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000009e7d94a>.
<http://rdf.freebase.com/ns/en.rituximab> <http://rdf.freebase.com/ns/base.bioventurist.bv_therapeutic.indication_or_disease> <http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000008c83039>.
<http://rdf.freebase.com/ns/en.rituximab> <http://rdf.freebase.com/ns/base.bioventurist.bv_therapeutic.indication_or_disease> <http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000008c83031>.
<http://rdf.freebase.com/ns/en.rituximab> <http://rdf.freebase.com/ns/base.bioventurist.bv_therapeutic.indication_or_disease> <http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000009e7d933>.
<http://rdf.freebase.com/ns/en.rituximab> <http://rdf.freebase.com/ns/base.bioventurist.bv_therapeutic.indication_or_disease> <http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000009e7d943>.
<http://rdf.freebase.com/ns/en.rituximab> <http://rdf.freebase.com/ns/base.bioventurist.bv_therapeutic.indication_or_disease> <http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000009e7d93a>.
<http://rdf.freebase.com/ns/en.rituximab> <http://rdf.freebase.com/ns/base.bioventurist.bv_therapeutic.indication_or_disease> <http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000009e7e524>.
<http://rdf.freebase.com/ns/en.rituximab> <http://rdf.freebase.com/ns/medicine.drug.cas_number> "174722-31-7".
_:zUaFDsvC1544 <http://rdf.freebase.com/ns/type.key.namespace> <http://rdf.freebase.com/ns/wikipedia.en>.
_:zUaFDsvC1544 <http://rdf.freebase.com/ns/type.value.value> "MabThera".
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000008c83039> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://rdf.freebase.com/ns/common.topic>.
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000008c83039> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://rdf.freebase.com/ns/base.bioventurist.indication>.
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000008c83039> <http://rdf.freebase.com/ns/base.bioventurist.indication.disease> <http://rdf.freebase.com/ns/en.non-hodgkin_lymphoma>.
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000008c83039> <http://rdf.freebase.com/ns/base.bioventurist.indication.phase_of_development> <http://rdf.freebase.com/ns/en.on_the_market>.
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000008c83039> <http://rdf.freebase.com/ns/base.bioventurist.indication.therapeutic> <http://rdf.freebase.com/ns/en.rituximab>.
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000008c83177> <http://rdf.freebase.com/ns/base.bioventurist.sales.company_reporting> <http://rdf.freebase.com/ns/en.genentech>.
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000008c83177> <http://rdf.freebase.com/ns/base.bioventurist.sales.area> <http://rdf.freebase.com/ns/en.world_wide>.
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000008c83177> <http://rdf.freebase.com/ns/base.bioventurist.sales.amount> "1831000000"^^<http://www.w3.org/2001/XMLSchema#long>.
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000008c83177> <http://rdf.freebase.com/ns/base.bioventurist.sales.year> "2005".
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000008c83177> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://rdf.freebase.com/ns/base.bioventurist.sales>.
_:zUaFDsvC1543 <http://rdf.freebase.com/ns/type.key.namespace> <http://rdf.freebase.com/ns/en>.
_:zUaFDsvC1543 <http://rdf.freebase.com/ns/type.value.value> "rituximab".
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000008c83031> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://rdf.freebase.com/ns/common.topic>.
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000008c83031> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://rdf.freebase.com/ns/base.bioventurist.indication>.
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000008c83031> <http://rdf.freebase.com/ns/base.bioventurist.indication.disease> <http://rdf.freebase.com/ns/en.rheumatoid_arthritis>.
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000008c83031> <http://rdf.freebase.com/ns/base.bioventurist.indication.phase_of_development> <http://rdf.freebase.com/ns/en.on_the_market>.
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000008c83031> <http://rdf.freebase.com/ns/base.bioventurist.indication.therapeutic> <http://rdf.freebase.com/ns/en.rituximab>.
_:zUaFDsvC1542 <http://rdf.freebase.com/ns/type.key.namespace> <http://rdf.freebase.com/ns/wikipedia.en>.
_:zUaFDsvC1542 <http://rdf.freebase.com/ns/type.value.value> "Mabthera".
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000009e7d933> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://rdf.freebase.com/ns/common.topic>.
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000009e7d933> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://rdf.freebase.com/ns/base.bioventurist.indication>.
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000009e7d933> <http://rdf.freebase.com/ns/base.bioventurist.indication.therapeutic> <http://rdf.freebase.com/ns/en.rituximab>.
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000009e7d933> <http://rdf.freebase.com/ns/base.bioventurist.indication.disease> <http://rdf.freebase.com/ns/en.lupus_erythematosus>.
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000009e7d933> <http://rdf.freebase.com/ns/base.bioventurist.indication.phase_of_development> <http://rdf.freebase.com/ns/en.phase_iii_clinical_trial>.
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000009e7d943> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://rdf.freebase.com/ns/common.topic>.
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000009e7d943> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://rdf.freebase.com/ns/base.bioventurist.indication>.
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000009e7d943> <http://rdf.freebase.com/ns/base.bioventurist.indication.therapeutic> <http://rdf.freebase.com/ns/en.rituximab>.
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000009e7d943> <http://rdf.freebase.com/ns/base.bioventurist.indication.disease> <http://rdf.freebase.com/ns/en.multiple_sclerosis>.
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000009e7d943> <http://rdf.freebase.com/ns/base.bioventurist.indication.phase_of_development> <http://rdf.freebase.com/ns/en.phase_iii_clinical_trial>.
_:zUaFDsvC1539 <http://rdf.freebase.com/ns/type.key.namespace> <http://rdf.freebase.com/ns/wikipedia.en_id>.
_:zUaFDsvC1539 <http://rdf.freebase.com/ns/type.value.value> "1228011".
_:zUaFDsvC1540 <http://rdf.freebase.com/ns/type.key.namespace> <http://rdf.freebase.com/ns/wikipedia.en>.
_:zUaFDsvC1540 <http://rdf.freebase.com/ns/type.value.value> "Rituximab".
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000008c83170> <http://rdf.freebase.com/ns/base.bioventurist.sales.company_reporting> <http://rdf.freebase.com/ns/en.genentech>.
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000008c83170> <http://rdf.freebase.com/ns/base.bioventurist.sales.area> <http://rdf.freebase.com/ns/en.world_wide>.
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000008c83170> <http://rdf.freebase.com/ns/base.bioventurist.sales.amount> "2300000000"^^<http://www.w3.org/2001/XMLSchema#long>.
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000008c83170> <http://rdf.freebase.com/ns/base.bioventurist.sales.year> "2007".
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000008c83170> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://rdf.freebase.com/ns/base.bioventurist.sales>.
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000009e7e524> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://rdf.freebase.com/ns/common.topic>.
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000009e7e524> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://rdf.freebase.com/ns/base.bioventurist.indication>.
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000009e7e524> <http://rdf.freebase.com/ns/base.bioventurist.indication.therapeutic> <http://rdf.freebase.com/ns/en.rituximab>.
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000009e7e524> <http://rdf.freebase.com/ns/base.bioventurist.indication.disease> <http://rdf.freebase.com/ns/en.chronic_lymphocytic_leukemia>.
<http://rdf.freebase.com/ns/guid.9202a8c04000641f8000000009e7e524> <http://rdf.freebase.com/ns/base.bioventurist.indication.phase_of_development> <http://rdf.freebase.com/ns/en.phase_iii_clinical_trial>.